“…Consistent with this, the low incidence of IBD among the Inuit has been attributed to their habitual high intake of n-3 fatty acids, particularly eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3) from marine foods (6). High dietary intakes of n-3 fatty acids have also shown therapeutic benefit in experimental models of colitis (1,36,37,49) and in several clinical studies including patients with ulcerative colitis and Crohn's disease (4,7,18,45). The absence of significant therapeutic efficacy in some clinical trials of n-3 fatty acids in patients with IBD (31,33) may be explained by differences in study design, patient selection, and the formulation, dose, and duration of n-3 fatty acids (6).…”